Today on the blog we share the latest information about monkeypox virus and discuss how effective Clinell products are at killing it.
Monkeypox is a viral infection caused by an enveloped virus which belongs to the Orthopoxvirus genus in the family Poxviridae.
Although the role of surfaces in the transmission of the virus is unclear, GAMA Healthcare have received several enquiries about the efficacy of Clinell products. Testing the efficacy of disinfectants (such as Clinell Universal) against viruses is assessed using efficacy standard EN14476.
EN14476 states that demonstrating efficacy against the vaccinia virus is sufficient to demonstrate efficacy against all enveloped viruses (of which monkeypox virus is one). Furthermore, monkeypox virus and vaccinia virus are very closely related, so this comparison is particularly relevant.
Clinell Universal Wipes and Clinell Peracetic Acid Wipes have been tested against enveloped viruses by independent labs according to EN14476. Clinell Universal and Clinell Peracetic Acid Wipes pass EN14476 producing a 4-log reduction (99.99% kill) against enveloped viruses in a 15 second contact time.
Typically, monkeypox infections are found in Central and Western African countries such as Nigeria, Liberia and Democratic of Congo. However, in the past few weeks, cases have been reported in Portugal, Spain and the UK.
The latest update (18th May), from the UK Health and Safety Agency (UKHSA), stated that in total 9 cases of monkeypox have been reported in London and the North East of England.
According to UKSHA, initial symptoms of monkeypox include fever, headache, muscle aches, backache, swollen lymph nodes, chills and exhaustion. A rash can develop, often beginning on the face, then spreading to other parts of the body including the genitals.
The infection is usually spread by close contact with an infected patient, however there is a very low risk of transmission to the general public. The sources of identified cases are being rapidly investigated by UKHSA and they are raising awareness among health professionals.
The emerging character of the disease has been attributed to:
Higher or more frequent exposure to animal reservoir species
Increased human-to-human transmission rate
Advances in diagnostic capacity and health education
The cessation of the smallpox vaccine and the drop in immunity against Orthopoxvirus
If you'd like to know more about the efficacy of our Clinell product range, please don't hesitate to contact us via our contact form. Help spread awareness of the virus by sharing this article on social media.
We caught up with GAMA's female engineers, Anria and Caroline. Th…
We've launched Clinell Biodegradable Surface Wipes! Read on to fi…
In honour of World Continence Week, GAMA's Clinical Specialist, G…
Our Clinical Directors, Karen Wares and Yvonne Carter, share thei…